|Videos|September 28, 2021

Behind the Science: Behind New Drugs for Obesity

The epidemic of chronic obesity in the US is driving increases in a wide range of other dangerous and deadly chronic illnesses. Prevention and management of overweight and obesity are rightly the concern of primary care but there are myriad challenges for both patients and physicians to arresting or reversing the process of unhealthy weight gain. There now are several physiologic that act on the physiologic underpinnings of obesity and may significantly enhance the success of patients’ efforts at behavioral change (eg, diet and physical activity).